Search research articles
Contact Us
Filters
Showing results (161-170 of 173) with videos related to
Page
of 18
Sort By:
JAMA Cardiology
|
March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial
Prem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 12, 2018
Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2017
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Circulation
|
November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Daniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 16, 2017
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Journal of the American College of Cardiology
|
August 29, 2024
ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery
, John U Doherty, Stacie L Daugherty, et al.
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
JACC. Cardiovascular Imaging
|
August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint
Leslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
JACC. Cardiovascular Imaging
|
February 22, 2025
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum
Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, et al.
Radiology. Cardiothoracic Imaging
|
November 1, 2023
Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison
Cole B Hirschfeld, Sharmila Dorbala, Leslee J Shaw, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 173) with videos related to
Sort By:
Page
of 18
JAMA Cardiology
|
March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial
Prem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 12, 2018
Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2017
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Circulation
|
November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Daniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 16, 2017
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Venkatesh L Murthy, Timothy M Bateman, Rob S Beanlands, et al.
Journal of the American College of Cardiology
|
August 29, 2024
ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery
, John U Doherty, Stacie L Daugherty, et al.
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
JACC. Cardiovascular Imaging
|
August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint
Leslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
JACC. Cardiovascular Imaging
|
February 22, 2025
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum
Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, et al.
Radiology. Cardiothoracic Imaging
|
November 1, 2023
Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison
Cole B Hirschfeld, Sharmila Dorbala, Leslee J Shaw, et al.
Page
of 18